PlainPharmaWatch

CMS Open Payments · Program Year 2024

Avyxa Pharma, LLC

Avyxa Pharma, LLC reported $17,196.19 in payments to 40 physicians and teaching hospitals across 40 transactions.

See the rankings → How this is sourced
$17.2K
Total payments
40
Transactions
40
Recipients
#1561
of 1,925 companies

Avyxa Pharma, LLC reported $17,196.19 in payments to 40 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1561 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $429.90 per recipient across 3 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Avyxa Pharma, LLC pairs modest payment volume with a moderately concentrated payment pattern.

#1561
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
3
payment categories

How Avyxa Pharma, LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Avyxa Pharma, LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$17,196 19th percentile higher than 19% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). This entry sits in this band. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Avyxa Pharma, LLC

$17,196.19: that is what Avyxa Pharma, LLC reported in payments to 40 physicians and teaching hospitals during Program Year 2024, spread across 40 transactions ($429.90 per transaction, $429.90 per recipient). The company sits at rank #1561 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $10.0K, accounting for 58.2% of the company's reported total and 4 transactions.

General Payment Breakdown by Type

Avyxa Pharma, LLC made 3 types of general payments. "Consulting Fee" is the largest category at $10.0K, 58.2% of the company's reported total.

How Avyxa Pharma, LLC divides its payments

How the reported total splits across payment categories

1. Consulting Fee$10.0K2. Honoraria$4.0K3. Food and Beverage$3.2K
Payment Type Amount Transactions
Consulting Fee $10.0K 4
Honoraria $4.0K 4
Food and Beverage $3.2K 32

Recipient Concentration in General Payments

The five largest recipient relationships account for $13,000.00 (75.6%) of $17,196.19 in this company's General Payments records across 38 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Avyxa Pharma, LLC

The five named recipients with the highest reported General Payments from this company

Vikram Gorantla$5.0KMohit Narang$5.0KSalim Contractor$1.0KRussell Gollard$1.0KGang Tian$1.0K
  1. 1

    Vikram Gorantla

    $5,000.00 across 2 reported transactions

  2. 2

    Mohit Narang

    $5,000.00 across 2 reported transactions

  3. 3

    Salim Contractor

    $1,000.00 across 1 reported transactions

  4. 4

    Russell Gollard

    $1,000.00 across 1 reported transactions

  5. 5

    Gang Tian

    $1,000.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $429.90. Average per recipient: $429.90.

Total Amount

$17,196.19

Avg per Transaction

$429.90

Avg per Recipient

$429.90

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Avyxa Pharma, LLC Share

0.0%

#1561 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Avyxa Pharma, LLC

Rattan And Associates

$17.3K 92 recipients

Afaxys, Inc.

$17.3K 28 recipients

Promega Corporation

$17.3K 24 recipients

Helios Cardio Inc

$17.4K 29 recipients

Body Vision Medical Inc.

$17.5K 98 recipients

Pfizer Chile S.a.

$16.9K 5 recipients

Frequently Asked Questions

How much did Avyxa Pharma, LLC pay to physicians and hospitals in 2024? ▾
Avyxa Pharma, LLC made $17,196.19 in payments to physicians and hospitals in Program Year 2024, across 40 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Avyxa Pharma, LLC? ▾
40 physicians and teaching hospitals received payments from Avyxa Pharma, LLC in 2024, averaging $429.90 per recipient.
What types of payments did Avyxa Pharma, LLC make? ▾
3 categories of general payment make up Avyxa Pharma, LLC's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $10.0K, representing 58.2% of the company's reported total.
How does Avyxa Pharma, LLC rank among pharmaceutical companies? ▾
By total payment amount, Avyxa Pharma, LLC sits at #1561 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Avyxa Pharma, LLC? ▾
In 2024, Avyxa Pharma, LLC averaged $429.90 per transaction across 40 transactions to 40 recipients.
Where does the payment data for Avyxa Pharma, LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Avyxa Pharma, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.